财新传媒
财新英文 > 要闻 > 正文

In Depth: A Tale of Two Verdicts in China’s Pharmaceutical Gray Market

By Xiao Hui
2026年04月03日 19:07
The same generic pills can lead to a six-year prison sentence in one Chinese province and a dropped case in another, exposing the inconsistent interpretation of the country's drug laws
Common generic male enhancement drugs from India circulating in the Chinese market. Photo: provided by interviewee

Years after public outcry over the high cost of domestic health care prompted Beijing to reform its stance on the illicit trade of unapproved but authentic overseas drugs, the legal landscape remains fraught with glaring inconsistencies.

  [财新双语通产品,是为有双语需求读者专门订制的优惠产品, 按此可享超值优惠订阅。]

版面编辑:喻竹杨洋
财新网主编精选版电邮 样例
财新网新闻版电邮全新升级!财新网主编精心编写,每个工作日定时投递,篇篇重磅,可信可引。
订阅